Cellectar Biosciences, Inc. (CLRB) — 10-Q Filings
All 10-Q filings from Cellectar Biosciences, Inc.. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (5)
-
Cellectar Narrows Losses 61% Amid Cash Burn, Going Concern Doubts
— Nov 13, 2025 Risk: high
Cellectar Biosciences, Inc. (CLRB) reported a significant decrease in net loss for the nine months ended September 30, 2025, narrowing to $16,495,816 from $42,2 -
Cellectar's Cash Dwindles Amidst Reduced Burn, Going Concern Looms
— Aug 14, 2025 Risk: high
Cellectar Biosciences, Inc. reported a net loss of $12,051,940 for the six months ended June 30, 2025, a significant improvement from the $27,561,355 net loss i -
Cellectar Biosciences Files Q1 2025 10-Q
— May 13, 2025 Risk: medium
Cellectar Biosciences, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information and business operations. Key financial -
Cellectar Biosciences Files Q3 2024 10-Q
— Nov 18, 2024 Risk: medium
Cellectar Biosciences, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported financial results and provided updates on its business -
Cellectar Biosciences Files 10-Q for Period Ending March 31, 2024
— May 14, 2024 Risk:
Cellectar Biosciences, Inc. (CLRB) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. Cellectar Biosciences, Inc. filed a 10-Q report for the period
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX